Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events
Annals of the Rheumatic Diseases · 2024
DOI: 10.1136/ard-2024-225664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2024. Verfasst von Dionysis Nikolopoulos und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece dsnikolopoulos@gmail…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antiphospholipid Syndrome, Gene Expression Profiling, Transcriptome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ulla o Roland Gustafssons Donationsfond, HORIZON EUROPE European Innovation Council, European Research Council.
Abstract (Originalsprache)
INTRODUCTION: Systemic lupus erythematosus with antiphospholipid syndrome (SLE-APS) represents a challenging SLE endotype whose molecular basis remains unknown. METHODS: We analysed whole-blood RNA-sequencing data from 299 patients with SLE (108 SLE-antiphospholipid antibodies (aPL)-positive, including 67 SLE-APS; 191 SLE-aPL-negative) and 72 matched healthy controls (HC). Pathway enrichment analysis, unsupervised weighted gene coexpression network analysis and machine learning were applied to distinguish disease endotypes. RESULTS: Patients with SLE-APS demonstrated upregulated type I and II interferon (IFN) pathways compared with HC. Using a 100-gene random forests model, we achieved a cross-validated accuracy of 75.6% in distinguishing these two states. Additionally, the comparison between SLE-APS and SLE-aPL-negative revealed 227 differentially expressed genes, indicating downregulation of IFN-α and IFN-γ signatures, coupled with dysregulation of the complement cascade, B-cell activation and neutrophil degranulation. Unsupervised analysis of SLE transcriptome identified 21 gene modules, with SLE-APS strongly linked to upregulation of the 'neutrophilic/myeloid' module. Within SLE-APS, venous thromboses positively correlated with 'neutrophilic/myeloid' and 'B cell' modules, while arterial thromboses were associated with dysregulation of 'DNA damage response (DDR)' and 'metabolism' modules. Anticardiolipin and anti-β2GPI positivity-irrespective of APS status-were associated with the 'neutrophilic/myeloid' and 'protein-binding' module, respectively. CONCLUSIONS: There is a hierarchical upregulation and-likely-dependence on IFN in SLE with the highest IFN signature observed in SLE-aPL-negative patients. Venous thrombotic events are associated with neutrophils and B cells while arterial events with DDR and impaired metabolism. This may account for their differential requirements for anticoagulation and provide rationale for the potential use of mTOR inhibitors such as sirolimus and the direct fIIa inhibitor dabigatran in SLE-APS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece dsnikolopoulos@gmail.com boumpasd@uoc.gr.
- 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
- Molecular Systems Biology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh, AG Groningen, Τhe Netherlands.
- Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Förderung
- Ulla o Roland Gustafssons Donationsfond
- HORIZON EUROPE European Innovation Council
- European Research Council
Zitieren
APA
Nikolopoulos, D., Loukogiannaki, C., Sentis, G., Garantziotis, P., Manolakou, T., Kapsala, N., Nikoloudaki, M., Pieta, A., Flouda, S., Parodis, I., Bertsias, G., Fanouriakis, A., Filia, A., & Boumpas, D. T. (2024). Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2024-225664
Vancouver
Nikolopoulos D, Loukogiannaki C, Sentis G, Garantziotis P, Manolakou T, Kapsala N, et al. Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Annals of the Rheumatic Diseases. 2024. doi:10.1136/ard-2024-225664
BibTeX
@article{Nikolopoulos2024,
author = {Nikolopoulos, Dionysis and Loukogiannaki, Catherine and Sentis, George and Garantziotis, Panagiotis and Manolakou, Theodora and Kapsala, Noemin and Nikoloudaki, Myrto and Pieta, Antigone and Flouda, Sofia and Parodis, Ioannis and Bertsias, George and Fanouriakis, Antonis and Filia, Anastasia and Boumpas, Dimitrios T},
title = {Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events},
journal = {Annals of the Rheumatic Diseases},
year = {2024},
doi = {10.1136/ard-2024-225664}
}
EUVIMED